SP
Sanjay Periwal
About Sanjay Periwal
Data last updated:
Sanjay Periwal is a Director at Morphogene Biotech Private Limited (since 2013). The companies operate in Agriculture and Financial Services. Morphogene Biotech Private Limited reported revenue of ₹22.7 Lakh (FY 2024). Earlier, Sanjay Periwal was a Director at Dhanganga Dealcomm Pvt.Ltd (2015–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Aug 2013 | 2013 | ₹22.7 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Mar 2015 | 1994 | ₹1.8 Lakh (FY 2020) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Periwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Karan Kumar Kakkad | 06979922 | Morphogene Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Periwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Periwal
Sanjay Periwal currently holds 1 directorship: Morphogene Biotech Private Limited (Director, since 26 Aug 2013, revenue ₹22.7 Lakh (FY 2024)).
Sanjay Periwal was first appointed on 26 Aug 2013 as Director at Morphogene Biotech Private Limited. The most recent appointment on record is 31 Mar 2015 at Dhanganga Dealcomm Pvt.Ltd.
Sanjay Periwal held 1 earlier board appointment: Dhanganga Dealcomm Pvt.Ltd (Director, 31 Mar 2015 to 15 Feb 2021).
The current boards of Sanjay Periwal's companies include Karan Kumar Kakkad (Morphogene Biotech Private Limited).